These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
697 related articles for article (PubMed ID: 32334820)
1. The COVID-19 pandemic and the use of MS disease-modifying therapies. Giovannoni G; Hawkes C; Lechner-Scott J; Levy M; Waubant E; Gold J Mult Scler Relat Disord; 2020 Apr; 39():102073. PubMed ID: 32334820 [No Abstract] [Full Text] [Related]
2. Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era. Ciotti JR; Grebenciucova E; Moss BP; Newsome SD Ann Neurol; 2020 Dec; 88(6):1062-1064. PubMed ID: 32951235 [No Abstract] [Full Text] [Related]
3. Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection? Ghajarzadeh M; Bonavita S Neurol Sci; 2020 Sep; 41(9):2315-2316. PubMed ID: 32638135 [No Abstract] [Full Text] [Related]
4. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic? Laxminarayan R; John TJ Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793 [No Abstract] [Full Text] [Related]
5. COVID-19 will change MS care forever - No. Preziosa P; Rocca MA; Filippi M Mult Scler; 2020 Sep; 26(10):1149-1151. PubMed ID: 32567471 [No Abstract] [Full Text] [Related]
6. Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic. Naser Moghadasi A; Azadvari M; Sahraian MA Arch Iran Med; 2020 Jul; 23(7):509-510. PubMed ID: 32657605 [No Abstract] [Full Text] [Related]
7. Developing Covid-19 Vaccines at Pandemic Speed. Lurie N; Saville M; Hatchett R; Halton J N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757 [No Abstract] [Full Text] [Related]
8. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity. Goudsmit J Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914 [No Abstract] [Full Text] [Related]
13. Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations. Blaszczak A; Trinidad JCL; Cartron AM J Am Acad Dermatol; 2020 Jul; 83(1):e31. PubMed ID: 32283230 [No Abstract] [Full Text] [Related]
14. Keeping track of the SARS-CoV-2 vaccine pipeline. Parker EPK; Shrotri M; Kampmann B Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290 [TBL] [Abstract][Full Text] [Related]
15. Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic? Ehtesham NZ; Samal J; Ahmad F; Arish M; Naz F; Alam A; Agrawal U; Hasnain SE Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):16-20. PubMed ID: 32859863 [No Abstract] [Full Text] [Related]
16. Should countries aim for elimination in the covid-19 pandemic? Lee A; Thornley S; Morris AJ; Sundborn G BMJ; 2020 Sep; 370():m3410. PubMed ID: 32909958 [No Abstract] [Full Text] [Related]
17. Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic? Megna M; Fabbrocini G; Marasca C Int J Dermatol; 2020 Sep; 59(9):1144-1145. PubMed ID: 32710548 [No Abstract] [Full Text] [Related]